| 摘要 |
<p>Pharmaceutical compositions or diagnostic products containing Pluronic F-127 are disclosed which contain a therapeutic or diagnostic active quantity of the active principle and from 18 to 19% by weight of the gel-forming Pluronic F-127, as well as a method for the preparation of said products.</p> |
